[1. Mahlknecht P, Seppi K, Poewe W. The Concept of prodromal Parkinson’s disease. J Parkinsons Dis. 2015;5(4):681–97.10.3233/JPD-150685492792426485429]Search in Google Scholar
[2. Hilker R, Schweitzer K, Coburger S, Ghaemi M, Weisenbach S, Jacobs AH, et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol. 2005 Mar;62(3):378–82.10.1001/archneur.62.3.37815767502]Search in Google Scholar
[3. Csoti I, Jost WH, Reichmann H. Parkinson’s disease between internal medicine and neurology. J Neural Transm. 2016 Jan;123(1):3–17.10.1007/s00702-015-1443-z471346226298728]Search in Google Scholar
[4. De Pablo-Fernandez E, Goldacre R, Pakpoor J, Noyce AJ, Warner TT. Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study. Neurology. 2018 Jul;91(2):e139–42.10.1212/WNL.000000000000577129898968]Search in Google Scholar
[5. Hu G, Antikainen R, Jousilahti P, Kivipelto M, Tuomilehto J. Total cholesterol and the risk of Parkinson disease. Neurology. 2008 May;70(21):1972–9.10.1212/01.wnl.0000312511.62699.a818401018]Search in Google Scholar
[6. Ajtay A, Oberfrank F, Bereczki D. [Applicability of hospital reports submitted for reimbursement purposes for epidemiological studies based on the example of ischemic cerebrovascular diseases]. Orv Hetil. 2015 Sep;156(38):1540–6.10.1556/650.2015.3025826550700]Search in Google Scholar
[7. Szatmari S Jr, Ajtay A, Balint M, Takats A, Oberfrank F, Bereczki D. Linking individual patient data to estimate incidence and prevalence of Parkinson’s disease by comparing reports of neurological services and pharmacy prescription refills at a nationwide level. Front Neurol. 2019;10:640.10.3389/fneur.2019.00640659146531275231]Search in Google Scholar
[8. Szigethy E, Szeles G, Horvath A, Hidvegi T, Jermendy G, Paragh G, et al. Epidemiology of the metabolic syndrome in Hungary. Public Health. 2012 Feb;126(2):143–9.10.1016/j.puhe.2011.11.00322226972]Search in Google Scholar
[9. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, et al. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer’s disease. Neuroepidemiology. 1998;17(1):14–20.10.1159/0000261499549720]Search in Google Scholar
[10. Kivipelto M, Helkala E-L, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, et al. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med. 2002 Aug;137(3):149–55.10.7326/0003-4819-137-3-200208060-0000612160362]Search in Google Scholar
[11. Paul R, Choudhury A, Kumar S, Giri A, Sandhir R, Borah A. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson’s disease: Involvement of mitochondrial dysfunctions and oxidative stress. PLoS One. 2017;12(2):e0171285.10.1371/journal.pone.0171285]Search in Google Scholar
[12. Paul R, Choudhury A, Borah A. Cholesterol - A putative endogenous contributor towards Parkinson’s disease. Neurochem Int. 2015 Nov;90:125–33.10.1016/j.neuint.2015.07.025]Search in Google Scholar
[13. Vikdahl M, Backman L, Johansson I, Forsgren L, Haglin L. Cardiovascular risk factors and the risk of Parkinson’s disease. Eur J Clin Nutr. 2015 Jun;69(6):729–33.10.1038/ejcn.2014.259]Search in Google Scholar
[14. Huang X, Abbott RD, Petrovitch H, Mailman RB, Ross GW. Low LDL cholesterol and increased risk of Parkinson’s disease: prospective results from Honolulu-Asia Aging Study. Mov Disord. 2008 May;23(7):1013–8.10.1002/mds.22013]Search in Google Scholar
[15. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006 Jan;5(1):64–74.10.1016/S1474-4422(05)70284-2]Search in Google Scholar
[16. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology. 1999 Dec;53(9):1937–42.10.1212/WNL.53.9.1937]Search in Google Scholar
[17. Friederich M, Hansell P, Palm F. Diabetes, oxidative stress, nitric oxide and mitochondria function. Curr Diabetes Rev. 2009 May;5(2):120–44.10.2174/15733990978816680019442097]Search in Google Scholar
[18. Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol. 2008 Nov;4(11):600–9.10.1038/ncpneuro092418978800]Search in Google Scholar
[19. Biosa A, Outeiro TF, Bubacco L, Bisaglia M. Diabetes mellitus as a risk factor for Parkinson’s disease: a molecular point of view. Mol Neurobiol. 2018 Nov;55(11):8754–63.10.1007/s12035-018-1025-929594935]Search in Google Scholar
[20. Pagano G, Polychronis S, Wilson H, Giordano B, Ferrara N, Niccolini F, et al. Diabetes mellitus and Parkinson disease. Neurology. 2018 May;90(19):e1654–62.10.1212/WNL.000000000000547529626177]Search in Google Scholar
[21. Schernhammer E, Hansen J, Rugbjerg K, Wermuth L, Ritz B. Diabetes and the risk of developing Parkinson’s disease in Denmark. Diabetes Care. 2011 May;34(5):1102–8.10.2337/dc10-1333311448221411503]Search in Google Scholar
[22. Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J. Type 2 diabetes and the risk of Parkinson’s disease. Diabetes Care. 2007 Apr;30(4):842–7.10.2337/dc06-201117251276]Search in Google Scholar
[23. Yang Y-W, Hsieh T-F, Li C-I, Liu C-S, Lin W-Y, Chiang J-H, et al. Increased risk of Parkinson disease with diabetes mellitus in a population-based study. Medicine (Baltimore). 2017 Jan;96(3):e5921.10.1097/MD.0000000000005921527910128099356]Search in Google Scholar
[24. Marko-Kucsera M, Vecsei L, Paulik E. Association of cardiovascular risk factors and Parkinson’s disease - case-control study in South East Hungary. Ideggyogy Sz. 2018 Jan;71(1–2):57–62.10.18071/isz.71.005729465901]Search in Google Scholar
[25. Lu L, Fu D-L, Li H-Q, Liu A-J, Li J-H, Zheng G-Q. Diabetes and risk of Parkinson’s disease: an updated meta-analysis of case-control studies. PLoS One. 2014;9(1):e85781.10.1371/journal.pone.0085781389752024465703]Search in Google Scholar
[26. Jain S. Multi-organ autonomic dysfunction in Parkinson disease. Parkinsonism Relat Disord. 2011 Feb;17(2):77–83.10.1016/j.parkreldis.2010.08.022302158720851033]Search in Google Scholar
[27. Mendoza-Velasquez JJ, Flores-Vazquez JF, Barron-Velazquez E, Sosa-Ortiz AL, Illigens B-MW, Siepmann T. Autonomic dysfunction in alpha-synucleinopathies. Front Neurol. 2019;10:363.10.3389/fneur.2019.00363647418131031694]Search in Google Scholar
[28. Fanciulli A, Gobel G, Ndayisaba JP, Granata R, Duerr S, Strano S, et al. Supine hypertension in Parkinson’s disease and multiple system atrophy. Clin Auton Res. 2016 Apr;26(2):97–105.10.1007/s10286-015-0336-426801189]Search in Google Scholar
[29. Umehara T, Matsuno H, Toyoda C, Oka H. Clinical characteristics of supine hypertension in de novo Parkinson disease. Clin Auton Res. 2016 Feb;26(1):15–21.10.1007/s10286-015-0324-826613721]Search in Google Scholar
[30. Qiu C, Hu G, Kivipelto M, Laatikainen T, Antikainen R, Fratiglioni L, et al. Association of blood pressure and hyper-tension with the risk of Parkinson disease: the National FINRISK Study. Hypertens (Dallas, Tex 1979). 2011 Jun;57(6):1094–100.10.1161/HYPERTENSIONAHA.111.17124921536985]Search in Google Scholar
[31. Jain S, Ton TG, Perera S, Zheng Y, Stein PK, Thacker E, et al. Cardiovascular physiology in premotor Parkinson’s disease: a neuroepidemiologic study. Mov Disord. 2012 Jul;27(8):988–95.10.1002/mds.24979365237722700356]Search in Google Scholar
[32. Li Q, Wang C, Tang H, Chen S, Ma J. Stroke and coronary artery disease are associated with Parkinson’s disease. Can J Neurol Sci. 2018 Sep;45(5):559–65.10.1017/cjn.2018.5630001757]Search in Google Scholar
[33. Simon KC, Chen H, Schwarzschild M, Ascherio A. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology. 2007 Oct;69(17):1688–95.10.1212/01.wnl.0000271883.45010.8a239107717761552]Search in Google Scholar
[34. Miyake Y, Tanaka K, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, et al. Case-control study of risk of Parkinson’s disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan. J Neurol Sci. 2010 Jun;293(1–2):82–6.10.1016/j.jns.2010.03.00220347450]Search in Google Scholar
[35. Scorza FA, Fiorini AC, Scorza CA, Finsterer J. Cardiac abnormalities in Parkinson’s disease and parkinsonism. J Clin Neurosci Off J Neurosurg Soc Australas. 2018 Jul; 53:1–5.10.1016/j.jocn.2018.04.03129706419]Search in Google Scholar
[36. Ronkainen J, Agreus L. Epidemiology of reflux symptoms and GORD. Best Pract Res Clin Gastroenterol. 2013 Jun;27(3):325–37.10.1016/j.bpg.2013.06.00823998972]Search in Google Scholar
[37. Aerts R, Penninckx F. The burden of gallstone disease in Europe. Aliment Pharmacol Ther. 2003 Nov;18 Suppl 3:49–53.10.1046/j.0953-0673.2003.01721.x14531741]Search in Google Scholar
[38. Cersosimo MG, Benarroch EE. Neural control of the gastrointestinal tract: implications for Parkinson disease. Mov Disord. 2008 Jun;23(8):1065–75.10.1002/mds.2205118442139]Search in Google Scholar
[39. Maeda T, Nagata K, Satoh Y, Yamazaki T, Takano D. High prevalence of gastroesophageal reflux disease in Parkinson’s disease: a questionnaire-based study. Parkinsons Dis. 2013;2013:742128.10.1155/2013/742128358311823476890]Search in Google Scholar
[40. Makaroff L, Gunn A, Gervasoni C, Richy F. Gastrointestinal disorders in Parkinson’s disease: prevalence and health outcomes in a US claims database. J Parkinsons Dis. 2011;1(1):65–74.10.3233/JPD-2011-00123939257]Search in Google Scholar
[41. Modaine P, Levy S, Masmoudi K, Capron D, Votte A, Josse C, et al. Parkinson’s disease: a new risk factor for gallstone disease? Vol. 23, Journal of hepatology. Netherlands; 1995. p. 484.10.1016/0168-8278(95)80213-4]Search in Google Scholar
[42. Maki T, Sonoda Y, Sugita K. [Gallstone and Parkinson’s disease--ultrasound echography study]. Rinsho Shinkeigaku. 1990 Jul;30(7):728–30.]Search in Google Scholar
[43. Gerstenbrand F, Poewe W. Dopaminergic-peptidergic interactions in extrapyramidal disorders: a review of the clinical evidence. Adv Neurol. 1987;45:67–73.]Search in Google Scholar